Shortage reports
Actual shortage:
283 (9%)
Anticipated shortage:
1 (0%)
Avoided shortage:
10 (0%)
Resolved:
2953 (91%)
3247
Discontinuation Reports
To be discontinued:
2 (0%)
Discontinued:
410 (94%)
Reversed:
23 (5%)
435
483 (13%)
16 (6%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-SPIRONOLACTONE | 25MG | TABLET | Resolved | 2021-02-25 | 2021-05-06 | 134749 |
| TEVA-SPIRONOLACTONE | 100MG | TABLET | Resolved | 2017-08-02 | 2018-02-21 | 18025 |
| TEVA-SPIRONOLACTONE | 25MG | TABLET | Resolved | 2020-08-13 | 2020-11-07 | 122217 |
| TEVA-SPIRONOLACTONE | 25MG | TABLET | Resolved | 2020-11-12 | 2021-01-28 | 128339 |
| TEVA-SPIRONOLACTONE | 100MG | TABLET | Resolved | 2023-06-16 | 2023-07-12 | 195225 |
| TEVA-SPIRONOLACTONE | 100MG | TABLET | Resolved | 2025-05-30 | 2025-08-08 | 258990 |
| TEVA-SPIRONOLACTONE | 25MG | TABLET | Resolved | 2017-03-13 | 2017-10-11 | 1568 |
| TEVA-SPIRONOLACTONE | 25MG | TABLET | Actual shortage | 2025-10-16 | 2025-12-11 | 269672 |
| TEVA-SPIRONOLACTONE | 100MG | TABLET | Resolved | 2021-03-18 | 2021-05-06 | 135949 |
| TEVA-SPIRONOLACTONE | 100MG | TABLET | Resolved | 2022-08-18 | 2022-12-15 | 167255 |
| TEVA-SPIRONOLACTONE | 100MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 1560 |
| TEVA-SPIRONOLACTONE | 25MG | TABLET | Resolved | 2025-04-04 | 2025-08-08 | 254139 |
| TEVA-SPIRONOLACTONE | 100MG | TABLET | Resolved | 2020-04-23 | 2020-05-08 | 113016 |
| TEVA-SPIRONOLACTONE | 25MG | TABLET | Resolved | 2018-03-13 | 2018-05-30 | 42604 |
| TEVA-SPIRONOLACTONE | 25MG | TABLET | Resolved | 2022-08-18 | 2023-04-28 | 167212 |
| TEVA-SPIRONOLACTONE | 100MG | TABLET | Resolved | 2025-08-29 | 2025-10-02 | 266178 |
| TEVA-SPIRONOLACTONE | 25MG | TABLET | Resolved | 2020-03-06 | 2020-03-26 | 107970 |
| TEVA-SPIRONOLACTONE/HCTZ | 25MG 25MG | TABLET | Resolved | 2020-11-06 | 2021-02-05 | 128022 |
| TEVA-SPIRONOLACTONE/HCTZ | 25MG 25MG | TABLET | Resolved | 2017-08-02 | 2017-11-07 | 18021 |
| TEVA-SPIRONOLACTONE/HCTZ | 50MG 50MG | TABLET | Resolved | 2023-10-26 | 2023-11-09 | 208251 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-VALSARTAN | 80MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256149 |
| TEVA-VALSARTAN/HCTZ | 25MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255833 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256140 |
| TEVA-VALSARTAN/HCTZ | 25MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256143 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255830 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255827 |
| TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-09-24 | 2020-09-24 | 124899 |
| TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117546 |
| TEVA-VORICONAZOLE | 50MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256169 |
| TEVA-VORICONAZOLE | 200MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256166 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-10-17 | 2019-10-17 | 96695 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-09-27 | 2019-10-01 | 94980 |
| ZOLEDRONIC ACID FOR INJECTION | 4MG | SOLUTION | Discontinued | 2025-05-28 | 2025-05-28 | 258583 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |